OpenAI Launches GPT-Rosalind: An AI to Accelerate Drug Discovery and Genomic Research OpenAI has launched GPT-Rosalind, an AI model designed to accelerate drug discovery and genomic research.
Gene editing and beta-thalassaemia: first clinical results A new gene-editing approach shows clinical results in beta-thalassaemia, with greater precision, fewer errors and reduced dependence on transfusions.